Compared with tamoxifen, aromatase inhibitors were revealed to be more effective in reducing the rate of recurrence in ER+ breast cancer among premenopausal women receiving ovarian suppression.
Lindsay Fischer
Advertisement
Articles by Lindsay Fischer
Advertisement
Latest Updated Articles
Premenopausal ER+ breast cancer recurrence reduced significantly with aromatase inhibitorsPublished: December 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Ayesha Dholakia, MD, discusses firearms as leading cause of US maternal death
2
Sex toy use linked to orgasm frequency in women over 60
3
Paracetamol use in pregnancy not clearly linked to autism or ADHD
4
Major gaps found in endometriosis policies worldwide
5
